aktana-logo.png
Aktana Launches Next Generation of its Contextual Intelligence Engine to Accelerate Enterprise-Wide AI Adoption
06 oct. 2021 07h24 HE | Aktana
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE)...
7 Hills Logo.png
Texas Heart Institute, University of Texas Medical Branch (UTMB) and 7 Hills Pharma Pioneer Significant Vaccine Research
01 oct. 2021 14h59 HE | 7 Hills Pharma
HOUSTON, TX., Oct. 01, 2021 (GLOBE NEWSWIRE) -- The Texas Heart Institute has announced that a research team led by its Vice President for Research Dr. Darren Woodside and Dr. Peter Vanderslice, of...
FourKites Named a Leader in Pharmaceutical Supply Chain Visibility Report
30 sept. 2021 07h30 HE | FourKites
CHICAGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- FourKites®, the world’s leading real-time supply chain visibility platform, announced that it has been named a Leader in CB Insights’ recent...
NJ Labs Celebrates 85 Years In the Testing Industry
29 sept. 2021 10h26 HE | NJ Labs
NEW BRUNSWICK, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- While Dr. David Levowitz was at Rutgers University, he saw a growing need to promote quality in dairy and food production, so he created New...
20170126-KnightL.jpg
Knight Therapeutics firma acuerdo de exclusividad con Incyte para el suministro y la distribución de Tafasitamab y Pemigatinib en Latinoamérica
23 sept. 2021 07h30 HE | Knight Therapeutics
MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), una compañía panamericana (ex- Estados Unidos) de especialidad farmacéutica, anunció hoy la firma de un...
20170126-KnightL.jpg
Thérapeutique Knight conclut une entente exclusive avec Incyte pour l’approvisionnement et la distribution de tafasitamab et de pemigatinib en Amérique latine
23 sept. 2021 07h30 HE | Thérapeutique Knight inc.
MONTRÉAL, 23 sept. 2021 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), société pharmaceutique spécialisée panaméricaine (ex-ÉU) a annoncé aujourd’hui...
20170126-KnightL.jpg
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America
23 sept. 2021 07h30 HE | Knight Therapeutics
MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, today announced that it has entered into a...
20170126-KnightL.jpg
Knight Therapeutics celebra acordo exclusivo de fornecimento e distribuição com a Incyte para Tafasitamabe e Pemigatinibe na América Latina
23 sept. 2021 07h30 HE | Knight Therapeutics
MONTREAL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- A Knight Therapeutics Inc. (TSX: GUD) (“Knight”), uma empresa farmacêutica especializada panamericana (ex-EUA), anunciou hoje que celebrou um acordo...
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
21 sept. 2021 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
New Report Shows 89% of Diabetics Worry About Broken Insulin Vials
15 sept. 2021 09h00 HE | SiO2 Materials Science
AUBURN, Ala., Sept. 15, 2021 (GLOBE NEWSWIRE) -- SiO2 Materials Science, a privately owned U.S.-based advanced materials science company, today released the findings from its new report: The Impact...